Document is current
Any future updates will be listed below
-
Authors
Tycko, Josh https://orcid.org/0000-0002-4108-0575
Van, Mike V.
Aradhana,
DelRosso, Nicole
Ye, Hanrong
Yao, David https://orcid.org/0000-0002-2232-524X
Valbuena, Raeline https://orcid.org/0000-0001-7877-4151
Vaughan-Jackson, Alun
Xu, Xiaoshu https://orcid.org/0000-0002-2989-4007
Ludwig, Connor
Spees, Kaitlyn
Liu, Katherine https://orcid.org/0000-0002-9616-9403
Gu, Mingxin
Khare, Venya
Mukund, Adi Xiyal
Suzuki, Peter H.
Arana, Sophia
Zhang, Catherine
Du, Peter P. https://orcid.org/0000-0003-2652-0541
Ornstein, Thea S.
Hess, Gaelen T. https://orcid.org/0000-0002-3836-0277
Kamber, Roarke A.
Qi, Lei S. https://orcid.org/0000-0002-3965-3223
Khalil, Ahmad S. https://orcid.org/0000-0002-8214-0546
Bintu, Lacramioara https://orcid.org/0000-0001-5443-6633
Bassik, Michael C. https://orcid.org/0000-0001-5185-8427
- License Information
-
More Information
Article History
Received: 8 May 2023
Accepted: 20 September 2024
First Online: 1 November 2024
Competing interests
: J.T., L.B. and M.C.B. are inventors on provisional patents related to this work and acknowledge outside interest in Stylus Medicine. L.S.Q. is a founder and scientific advisory board member of Epicrispr Biotechnologies and Refuge Biotechnologies. X.X. and L.S.Q. are inventors on provisional patents related to dCasMINI. A.S.K. is an inventor on patents related to synZiFTR, is a scientific advisor for and holds equity in Senti Biosciences and Chroma Medicine and is a cofounder of K2 Biotechnologies. All other authors declare no competing interests.
